Arkolith/Insider Trading/JAGX/Form 4

Lizak Carol R.

Chief Financial OfficerJaguar Health, Inc. (JAGX) · full profile →Form 4 · filed Apr 2, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 31, 2025Buy(P)5K$30000.00$162.0M5K
Mar 31, 2025Buy(P)5K——5K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-049802) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML